Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study
Clinical trial NCT00706134 · COMPLETED
Trial details
- NCT number
- NCT00706134
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 756
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.